Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?

19 Sept 2023

Abstract excerpt

BACKGROUND AND PURPOSE: Hereditary transthyretin amyloidosis (ATTRv) is a life-threatening disease caused by mutations in the gene encoding transthyretin (TTR). The recent therapeutic advances have underlined the importance of easily accessible, objective biomarkers of both disease onset and progression. Preliminary evidence suggests a potential role in this respect for neurofilament light chain (NfL). In this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Amyloidosis: Diagnosis, Treatment, Outcomes
Share to Skin and Cellular Biology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37724995
DOI: 10.1111/ene.16070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?PMID 37724995Read ↗

Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy.Semantic proximity Read ↗

Neurofilament Light Chain in Systemic Amyloidosis: A Systematic ReviewSemantic proximity Read ↗

Early detection of nerve involvement in presymptomatic TTR mutation carriers: exploring potential markers of disease onset.Semantic proximity Read ↗

Serum Neurofilament Light Chain Is Not an Independent Predictor of Autonomic Neuropathy in Hereditary Transthyretin AmyloidosisSemantic proximity Read ↗

Exploring the role of glial fibrillary acid protein and neurofilament light chains in patients with hereditary transthyretin amyloidosis with polyneuropathy.Semantic proximity Read ↗

Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosisSemantic proximity Read ↗

Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis − correlation between neurofilament light chain and nerve conduction studySemantic proximity Read ↗

Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.Semantic proximity Read ↗

Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapiesSemantic proximity Read ↗

Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations*Semantic proximity Read ↗

Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.Semantic proximity Read ↗

Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.